The thyroid hormones act directly on mitochondria, and thereby control the transformation of the energy derived from oxidations into a form utilizable by the cell. Through their direct actions on mitochondria, the hormones also control indirectly the rate of protein synthesis and thereby the amount of oxidative apparatus in the cell. A rationale for the effects of thyroid hormone excess or deficiency is based upon studies of the mechanism of thyroid hormone action. In hypothyroidism, slow fuel consumption leads to a low output of utilizable energy. In hyperthyroidism, rapid fuel consumption leads to a high energy output, but as efficiency decreases, the utilizable energy produced decreases. Many of the chemical and physical features of these diseases can be reduced to changes in available energy.
either that the variety of the effects they produce are due to a few types of primary interactions at the molecular level, or that the hormones are changed in the body to analogues each having a different and specific physiologic *Abbreviations: L-T,, L-thyroxine; L-T,, L-triiodothyronine; Triac, triiodothyroacetic acid; ATP, ADP and AMP, adenosine tri-, di-and mono-phosphate; P1, inorganic phosphate; NADH and NADPH, reduced nicotinamideadenine dinucleotide and dinucleotide phosphate; DNP, 2,4-dinitrophenol; BMR, basal metabolic rate (0O consumption).
effect. The preponderance of evidence at present supports the first hypothesis. It seems feasible therefore to attempt to reduce the complex pathologic pictures to subcellular phenomena and their consequences.
Recent advances in the understanding of where and how the thyroid hormones act in the cell support a simplification of thyrotoxicosis and hypothyroidism, although our understanding is not as yet so far advanced as to permit a final 'explanation' of the diseases in molecular terms. A brief history of the evolution of studies on the mechanism of thyroid hormone action serves to outline the present state of knowledge, the areas in which future advances may be made, and a basis for a rationale of hyperthyroidism and hypothyroidism.
Actions and effects of thyroid hormones Ever since Magnus-Levy (1895) showed that the thyroid gland controlled the rate of oxygen consumption in mammals, attention has been fixed on oxidative processes as a target of the hormone. Kendall (1929) The differentiation between actions and effects makes no judgement on their relative importance in the cell. The thyroid hormones are peculiarly suitable for the resolution of primary actions from secondary effects, because their iodine moieties can be used experimentally as a tracer for quantitative analysis. Methods for detecting other hormones not possessing this useful property are less specific or more tedious.
As will be detailed below, the thyroid hormones were shown to affect mitochondria as 2,4-dinitrophenol did: both agents increased mitochondrial respiration, and the energy liberated was transformed into heat rather than into the normal utilizable form, the high-energy phosphate bond. This toxic, catabolic, energywasting effect served as a rationale for thyrotoxicosis (Hoch, 1962a) , but not for the anabolic energy-conserving effects that the smaller doses of thyroid hormones exerted in euthyroid or hypothyroid subjects (Hoch, 1962b) . Nor was hypothyroidism made more understandable by the 'uncoupling' hypothesis. Accordingly, attention was directed away from the mitochrondrion in the search for the mechanism.
In the early 1960s the groups of Tata and of Sokoloff showed that thyroid hormones affected protein synthesis. It had been demonstrated earlier by Dutoit (1952) that protein was synthesized abnormally slowly in the livers of hypothyroid rats. L-T3 given in vivo accelerated the synthesis of proteins by ribosomes after about 48 hr after injection; the doses necessary were small and physiologic, smaller than those producing uncoupling in mitochondria, and the effect of the hormone was obviously anabolic (see Tata, 1967) . Puromycin and actinomycin D, agents that block protein synthesis by acting on nucleic acids, blocked the calorigenic action of thyroid hormones (Tata, 1963; Weiss & Sokoloff, 1963) . No changes were observed in mitochondrial respiratory control after hormone injection . Respiratory acceleration could be demonstrated in mitochondria 70-90 hr after hormone injections, but it was due to increases in the number of depleted respiratory assemblies in the mitochondria of hypothyroid rats Roodyn, Freeman & Tata, 1965) , and so represented the specific results of earlier protein synthesis. Increases in nuclear RNA-metabolism were shown early (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) hr) after hormone injection (Tata & Widnell, 1966) , then increases in ribosomal RNA-content and aggregation (about 40 hr) (Tata, 1967) . However, although all these phenomena showed an important relationship between the thyroid hormones and the processes supplying information to and controlling the rate of protein synthesis, they did not show the primary locus of hormone action. When L-T3 was added to isolated nuclei, RNA-metabolism was not stimulated (Widnell & Tata, 1963; Tata & Widnell, 1966; Sokoloff, Francis & Campbell, 1964 The studies of Sokoloff (Sokoloff & Kaufman, 1959 Sokoloff et al., 1963 Sokoloff et al., , 1964 have recently drawn attention back to the mitochondrion as a site of action of the hormone (Fig. 2) (Hoch, 1968a) . Bronk (1966) has also shown a very short latent period for L-T8. In hypothyroid rats, a subcalorigenic dose of L-T4 (at least fifty times less than those used to stimulate protein synthesis) partly corrected the excessive respiratory control in liver mitochondria 3 hr after injection (Hoch, 1966) . A larger dose did the same when the rats were killed 2 min after injection (Hoch, , 1968b . The hormone content of mitochondria, as measured by the total iodine or the butanolextractable iodine, was 20% of normal in untreated hypothyroid rats, and rose progressively with the functional changes up to 3 hr after injection Dillon & Hoch, 1968) (Hoch & Motta, 1968 The efficiency of phosphorylation, the P:O ratio, is the number of moles of high-energy phosphate produced per gram atom of oxygen consumed. This ratio is 3 for most compounds oxidized via diphosphopyridine-nucleotide-dependent dehydrogenases. The translation of the energy liberated by oxidation into phosphorylbond energy has been termed 'coupling' by mechanical analogy (Loomis & Lipmann, 1948 (Fig.  6) ; addition of ADP does not then accelerate the already rapid respiration. Low concentrations of uncoupling agents, insufficient to decrease the efficiency of phosphorylation measurably, also increase oxygen consumption and lower respiratory control; this is termed 'loose coupling' (Fig.   7 ). The mechanism that ordinarily limits the rate of respiration when ADP is absent (i.e. when -X,-.P remains undischarged) now permits both rapid respiration and transfer of energy. L-T4 and L-T3 can act like uncoupling agents in many respects. Large doses in vivo and high concentrations in vitro uncouple oxidative phosphorylation (see Hoch, 1962b; Hoch & Lipmann, 1954; Maley & Lardy, 1953; Martius & Hess, 1952) . By either route, the hormone accelerates the State 4 oxidation of most substrates and depresses the respiratory control. Much smaller doses or concentrations also lower respiratory control by raising State 4 oxidation, but they do not depress the P: ratio (see Fig. 7 ), nor interfere with the inhibitory action of oligomycin (Hoch, 1968b) , an agent specific for phosphorylating respiration.
Mitochondria from hypothyroid animals, that contain only 20% of the normal amount of thyroid hormone, are 'over-coupled', respiring too slowly in State 4 with excessive respiratory control (Maley & Lardy, 1955) , as in Fig. 8 seems that the optimal amount of L-T4 is necessary to poise mitochondrial energy-transfer between inertia and inefficiency.
Consideration of oxidative power as an index of the performance of the mitochondrial mechanism offers a basis for rationalizing many of the diverse effects of the thyroid hormones. In Fig. 9 , oxidative power is viewed as a resultant of changes in the rate of oxidation and/or the efficiency of energy transfer (Hoch, 1962a (Hoch, , 1968a (Sokoloff & Kaufman, 1961) . However, the differences between the thyroid hormones and the uncoupling agents should be stressed at this point: certain effects of the thyroid hormones are biologically specific. Agents like DNP do not relieve all the defects seen in hypothyroid subjects, nor do they stimulate growth and development, nor do they induce metamorphosis in Anura. The specificity must reside in the differences between their actions at the mitochondrial level. The mechanisms of action of thyroxine and DNP are known to differ: thyroxine makes mitochondria swell and DNP does not; and thyroxine and DNP act synergistically on mitochondrial respiration, not additively.
At least two factors may govern the effect of thyroid hormones: the thyroid state of the organism (presumably a function of the concentration of thyroid hormone in contact with the target sites) and the additional amount of the administered hormone reaching the target. Thus, thyroid hormone given to a hypothyroid subject raises oxidative metabolic power to normal levels; similar dosage in a euthyroid subject increases power above normal; higher dosage decreases power.
Late compositional changes
The functional changes in mitochondrial respiration discussed in the previous section involve specific respiratory activity, in the sense of the rate of respiration per amount of respiring mass. The thyroid hormones also affect the total respiratory mass in the mitochondrion. They control, through protein synthesis, the amount of respiratory enzymes per gram of total protein in the mitochondrion. In hypothyroidism, the rate of protein synthesis is lower than normal.
Mitochondria from hypothyroid rats contain half as much cytochrome b, c, and a+a3 as normal mitochondria (Maley, 1957; Kadenbach, 1966) Thyroid-treated rats and humans synthesized cholesterol more rapidly than normal (Kritchevsky, 1960) , and the hypocholesterolaemia of thyrotoxicosis, anomalous in the face of increased synthesis, was ascribed to the hormonal stimulation of cholesterol excretion (Rosenman, Byers & Friedman, 1952) . Increased rates of cholesterol and fatty acid synthesis have been observed in hormone-treated rats and in their tissue slices (Karp & Stetten, 1949; Dayton et al, 1960 ).
On the other hand, decreased rates of cholesterol synthesis were observed in liver homogenates (Scaife & Migicovsky, 1957) and cellfree preparations (Fletcher & Myant, 1962 ) from thyrotoxic rats. The cholesterol and neutral fat contents of the livers of thyroxine-treated rats (Handler, 1948) , and the fat content of human bodies (Wayne, 1960) were below normal in hyperthyroidism. Thyroidectomy also decreased the rate of cholesterol synthesis (Boyd, 1959) ; the low rate of synthesis of cholesterol and fatty acids in myxoedematous subjects was raised to normal by thyroid hormones (Lipsky et al., 1955) However, the control of lipid synthesis by thyroid hormones has also been observed in tissue preparations that were supposed to be free of mitochondria (Fletcher & Myant, 1960 (Deitrich & Smith, 1960) , earlier than it raised the basal metabolic rate (Abelin & Kiirsteiner, 1928 (Debons & Schwartz, 1961) and hypothyroidism abolishes it.
The fat-mobilization effects of insulin are similarly affected by the thyroid state, insulin releasing six times more free fatty acids from the adipose tissue of T4-injected rats than normally (Hagen, 1960 (Chatagner & Gautheron, 1960; Berg, 1937) . Increases in synthetic rates have also been observed, however, after single doses (Sternheimer, 1939) or more prolonged hormone treatment followed by liver perfusion with large amounts of glucose (Burton, Robbins & Byers, 1958 (Dow & Allen, 1961) . Hypothyroidism depressed glucose exidation via both paths (Dow & Allen, 1961) . The mechanisms of the thyroid hormonal effects on glycolysis may be via one or more routes. An effect of thyroxine on the cytoplasmic acylphosphatase of rat liver and muscle has been demonstrated: administered hormone increases acylphosphatase activity, thyroidectomy decreases it, and then low doses of T4 restore it (Harary, 1958) . This enzyme hydrolyses 1,4-diphosphoglycerate to Pi and 3-phosphoglycerate; it acts as a rate-limiting ATPase, uncoupling glycolysis from phosphorylation, and accelerates both glycolysis (by supplying Pi) and mitochondrial oxidation (by supplying ADP). And the activity of two enzymes of the glycolytic pathway, enolase and lactic dehydrogenase, were increased in the livers of thyrotoxic rats (Bargoni et al., 1961 ), but they are probably not rate-controlling steps; the activities of a number of the glycolytic enzymes were decreased in hypothyroidism (Bargoni et al., 1964) . Lastly, the hormonal control of the generation of NADH and NADPH by mitochondria might also affect both glycolysis and the phosphogluconate pathway (Dow & Allen, 1961 The rates of glucose utilization may also be affected through a hormonal control of hexose phosphorylation. Thyrotoxicosis raised the activity of intestinal phosphokinases (Nishikawara & Gabrielson, 1961) , and the observed delays in the tolerance curves for glucose and galactose in this condition have been ascribed to rapid phosphorylation and intestinal absorption (Althausen, 1940) . However, the importance of the phosphokinases in absorption has been questioned (Nishikawara & Gabrielson, 1961) . The utilization rate of glucose, measured under constant intravenous load, is reported to be normal in thyrotoxicosis (Macho, 1958) and normal in hypothyroidism (Macho, 1961) ; in hypothyroidism, administration of thyroxine or DNP rapidly (4 hr) accelerated the utilization rate, suggesting that these two agents act similarly.
Intravenous glucose-tolerance tests gave high disappearance rates in hyperthyroid patients and low rates in hypothyroids; tolbutamide decreased blood glucose faster in hyperthyroids and slower in hypothyroids; and glucagon induced a lower glucose response in hyperthyroids (Lamberg, 1965) . Orally administered D-xylose was normally absorbed by patients with thyrotoxicosis or myxoedema, but oral or intravenous D-xylose was excreted in the urine more rapidly in thyrotoxicosis, and less rapidly in myxoedema (Broitman et al., 1964) . Thyroid hormones potentiate insulin action; insulin-induced hypoglycaemia was increased in human thyrotoxicosis (Elrick, Hlad & Arai, 1961) , and the uptake of glucose by rat adipose tissue was more sensitive to insulin after thyroxine was injected (Hagen, 1960) .
Muscle contraction and creatine metabolism Thyroid hormones control muscle contraction and creatine metabolism. In human hypothyroidism, skeletal muscles are larger and firmer than normal and contract slowly because of an abnormality in the contraction mechanism (Millikan & Haines, 1957) . The clinical sign of the 'hung-up' reflex, with its slow relaxation, reflects this defect. In hyperthyroidism, muscle contracts at the normal rate, but performs work inefficiently (Plummer & Boothby, 1923) . Clinically, 'thyrotoxic myopathy' (Thorn & Eder, 1946; Hed, Kirstein & Lundmark, 1958) reflects this defect. Thyroxine has a biphasic effect on muscular work in adrenalectomized rats, a low dose improving the work done per contraction, and a four-times-higher dose decreasing it (Ganju & Lockett, 1958) .
The relation between muscle contraction and thyroid state thus seems clearer than in the case of some of the synthetic processes, probably because muscle contraction and relaxation depend more directly upon ATP supplied by mitochondrial oxidative phosphorylation. The other source of muscle ATP, the r-P of phosphocreatine, can support only a few contractions and must itself be replenished from mitochondrial energy transformations. The skeletal muscles of thyrotoxic rats showed uncoupling (Johnson et al., 1958) , and those of thyrotoxic humans showed loose coupling (Ernster, Ikkos & Luft, 1959) . In our terms, these mitochondria showed the action of the excessive amounts of thyroid hormones present. Other studies on apparently similar patients have shown normal muscle mitochondrial respiratory control, and either high controlled (State 4) and maximal (State 3) respiration (Stocker, Samaha & De Groot, 1966) or normal levels of respiration (Dow, 1967; Peter & Lee, 1967) ; because bovine serum albumin was used in the preparation and assay of the mitochondria, these results may show only the underlying enzymatic composition of the muscle mitochondria as contrasted with the action of the excessive amounts of hormone present in situ.
Heart muscle mitochondria are particularly susceptible to thyroid hormones (Bing, 1961) . Clinically, this seems to be reflected in the high incidence of myocardial failure in thyrotoxicosis (the increased work load and decreased efficiency of contraction are an unfortunate combination), and in the lack of response of this form of failure to digitalis (which is more effective against mechanically induced defective contractile mechanisms).
Alterations in creatine metabolism usually involve muscle. A rationale for the observations is shown in Fig. 10 . Clinically and experimentally, hyperthyroidism is accompanied by increased creatine excretion, and hypothyroidism by de-creased creatine excretion. In hyperthyroidism, creatine synthesis was normal (Wilkins & Fleischmann, 1946) . Injection of thyroxine rapidly depleted muscle phosphocreatine content, well before creatine excretion rose (Wang, 1946) , suggesting a hormonal effect of phosphorylation. Thyrotoxic humans excreted creatine administered to them, or endogenously synthesized, in contrast to normal subjects, because of an inability to 'fix' creatine in their muscles, i.e. to resynthesize phosphocreatine from creatine and ATP (Shorr, Richardson & Wolff, 1933; Thorn, 1936) . The defective creatine load-test is so characteristic that it has been used diagnostically. Creating phosphate (Cr -P), usually in equilibrium with the generated ATP, dissociates in hyperthyroidism to maintain the ATP level. The extra free creatine (Cr) and phosphate (Pi) are excreted. The Pi pool is augmented through inefficiency of oxidative re-esterification. Similarly, administering extra Cr in a load test augments the Cr-pool and subsequent excretion.
Vitamin metabolism
The thyroid hormones control the utilization of the water-soluble vitamins and their synthesis into coenzymes. The synthetic steps affected are usually energy-requiring condensations and phosphorylations. Most of the information is available on thyrotoxic subjects, where conditioned vitamin deficiences exist (Drill, 1943; Rawson, Rall & Sonenberg, 1955) . Normal intake of vitamins is accompanied by deficiency symptoms because of increased demands or defective utilization.
Thiamine requirements are increased in hyperthyroid patients. The blood and liver vitamin contents were subnormal, and the excretion was higher than normal (Williams et al., 1943) . Tissue cocarboxylase content was low in hyperthyroid rats; it rose after thiamine was injected, but then fell more rapidly than in euthyroid animals, suggesting rapid destruction (Peters & Rossiter, 1939) . Pyridoxine availability is limited in the tissues of hyperthyroid animals (Wohl et al., 1960) . Pyridoxal-5-phosphate content was low because of defective phosphorylation; conversely, it was high after thyroidectomy (Labouesse, Chatagner & Jolles-Bergeret, 1960) . Vitamin B12 content was low in the tissues of thyrotoxic rats and hypothyroid female rats (Gershoff et al., 1958; Kasbekar et al., 1959) ; hormone administration raised renal B12 to normal in hypothyroid rats, and above normal in euthyroid rats (Okuda & Chow, 1961) . Ascorbic acid content was low in the blood and tissues of thyrotoxic subjects. Pantothenic acid and CoA metabolism have been discussed under 'Lipid metabolism', and follow the same general pattern as the other water-soluble vitamins.
The thyroid hormones also control the synthesis of a fat-soluble vitamin. Vitamin A synthesis requires thyroid hormone. Both hypo-and hyperthyroid patients had poor dark adaptation (Wohl & Feldman, 1939) . In hypothyroidism serum vitamin A was decreased because carotene was not converted to the vitamin; hormone treatment restored synthesis (Drill & Truant, 1947; Johnson & Baumann, 1947) . In euthyroid animals, the hormone increased vitamin A synthesis, but prolonged treatment produced a severe resistant vitamin A deficiency (Portugal'skaya, 1961) , another example of the hormone's biphasic effect.
Metabolism of inorganic ions
Phosphorus metabolism is strongly influenced by the thyroid state. Hyperthyroid patients are in negative phosphorus balance (Rawson et al., 1955) . Hypothyroid patients excreted large amounts of phosphate soon after administration of the hormone, probably because of increased phosphocreatine hydrolysis (Beaumont, Dodds & Robertson, 1940; Flach et al., 1959) . Phosphate contents were high, and ATP contents were low, in the soft tissues of thyrotoxic animals (Berg, 1937; Chatagner & Gautheron, 1960; Maley, 1957) . The esterification of phosphate was slow in such tissues (Johnson et al., 1958) . In the bones of hyperthyroid patients, phosphate was turned over abnormally rapidly (Hernberg, 1960) probably in conjunction with the changes in calcium.
Calcium metabolism also changes in thyroid disease. Calcium turnover in bones is accelerated in hyperthyroid patients, and becomes normal with the thyroid state upon treatment (Krane et al., 1956 ). Calcium accumulation was more striking in the livers than in the bones of thyroxine-treated rats; the capacity of liver mitochondria to store Ca++ may be involved. In hypothyroid rats, calcium incorporation into bone was decreased (Lengemann, Wasserman & Comar, 1960) Hoch, 1962b) . Myxoedematous patients excreted large amounts of Mg++ in their urine promptly after hormone administration (Tapley, 1955) . The plasma magnesium content was low in hyperthyroidism and high in hypothyroidism; Mg balance was positive in hyper-and negative in hypothyroidism; total and cellular exchangeable Mg++ was strikingly low in hypothyroidism but normal in hyperthyroidism (Jones et al., 1966) . The effect of administering magnesium salts upon thyrotoxicosis is controversial, some finding a decrease in BMR and heart rate (Hueber, 1939) , others finding no decrease in BMR nor change in negative nitrogen and phosphate balances Wiswell, 1961) .
Decreased exchangeable potassium (Munro, Renschler & Wilson, 1958; Wayne, 1960) and hyperkalaemia and hyperkaluria (Boekelman, 1948) (Hoch, 1965a) dinitro-o-cresol (Barker, 1946) and methylene blue (Alwall, 1936) ; phosphate ions given by infusion (Roberts et al., 1956) ; and antipyretic agents, like sodium salicylate (Hoch, 1965a) . A dose of salicylate too small to raise the BMR in a normal rat raises the BMR sharply in a midly hyperthyroid rat; one-quarter of the normally lethal dose of salicylate rapidly induces a fatal hyperthermia in such hyperthyroid rats. With dinitrophenol, this phenomenon can be shown to arise from an exaggerated sensitivity of mitochondria to the uncoupling agent, induced by thyroxine treatment (Hoch, 1968c) . Whether the clinical phenomenon has a similar basis remains to be seen. The association of thyroid crisis in thyrotoxic patients with infections that cause fever (Means, De Groot & Stanbury, 1963) (Hoch, 1965b) , because their mitochondria are subnormally sensitive (Hoch, , 1968c . Administered thyroxine rapidly raises mitochondrial responses, and the efficiency of such treatment clinically may be evidence for a common basis for the hypothermia.
Effects of hormones and drugs
The effects of a number of hormones and drugs depend upon the thyroid state of the subject, as has been mentioned above in connection with specific systems. In general, hyperthyroidism exaggerates and hypothyroidism minmizes the changes seen after administration of the agent. Physiologically, the clearest example is that of the catecholamines. The relationship is so striking that some have concluded that the apparent peripheral effects of thyroxine are actually effects of epinephrine (Brewster et al., 1956 ), but there is evidence against so sweeping a claim (see Hoch, 1962b Leduc, 1960) , the amine oxidases (Zile & Lardy, 1959) , and a peroxidase system (Klebanoff, 1959) have been studied, but it is still difficult to assign physiologic relevance to the mechanisms. Another enzymatic system under scrutiny in this regard involves the formation of cyclic-3',5'-AMP, the mediator of many of the catecholamine effects. Thyroid hormones have been suggested to control the activation of the lipase in adipose tissue via a mechanism involving cyclic-3',5'-AMP (Fisher & Ball, 1967 ). Yet other possible routes are the control the thyroid hormones exert over ATP availability, since ATP is the only source of cyclic-3',5'-AMP; and the sensitivity of mitochondria. Adrenochrome and thyroxine act synergistically on mitochondria in vitro (Park, Meriwether & Park, 1956 ). The glycogenolytic and hyperglycaemic, the lipolytic, the inotropic, and the calorigenic effects of epinephrine all depend upon the thyroid state (see Ellis, 1956; Brodie et al., 1966; Goodman & Bray, 1966) . The abnormally slow pulse rate after epinephrine administration in hypothyroid patients, and the rapid rate in hyperthyroid subjects, have been used diagnostically, although caution is advised in hyperthyroids (Goetsch & Ritzmann, 1934) .
The dependence of the calorigenic effect of epinephrine upon the thyroid state is an example of the generality that the thyroid state controls the response of the body to calorigenic substances. Excessive rise in BMR is seen in hyperthyroidism, and little or no rise is seen in hypothyroidism, after the administration of glucagon (Davidson, Salter & Best, 1960) , nitrophenols, salicylates (Hoch, 1965a, b) , chloropromazine (unpublished data), and 'febrile toxins' (above). The only exception seems to be the enhanced sensitivity of hypothyroid subjects to the thyroid hormone itself. (Means et al., 1963) . A pituitary factor, possibly associated with thyrotropin, may be responsible (Loeb & Friedman, 1932) . The frequent persistence of exophthalmos after the therapeutic restoration of euthyroidism speaks for such a secondary relationship.
In the second category are those clinical features that may (and indeed seem to) arise from changed amounts of tissue thyroid hormone, but that are not reducible to cellular phenomena because we don't know enough yet. The hyperirritability of the nervous system in hyperthyroidism, and its opposite in hypothyroidism, may be presenting symptoms clinically. The involvement of ATP in nerve conduction and in resynthesis of acetylcholine at the myoneural junction, and the involvement of K+, Ca++ and Mg++ in neural events make it likely that hormoneinduced defects in energy transfer and ion accumulation will affect the nervous system, but just how changes in nerve function relate to 'nervousness' presents complex problems not yet conclusively approached. Similarly, the presenting abnormality of 'myxoedema' seems to be a defect in mucopolysaccharide metabolism that leads to excessive deposition, somehow and presumably dependent upon insufficient thyroid hormone.
The thyroid hormones obviously control growth, development, and the striking structural and chemical changes in Anuran metamorphosis. In general terms we may say these processes must depend upon available 'energy' but our lack of knowledge of the details of the energydependent steps precludes a mechanistic interpretation at present. In this area, however, the recent evidence that the thyroid hormones con-trol mitochondrial energy metabolism directly and promptly, and thereby regulate protein synthesis, offers promise of new and important information on biologic and medical problems.
